Photodiagnosis and photodynamic therapy | 2021
A case of recalcitrant neovascular wet age-related macular degeneration treated with Intravitreal Brolucizumab.
A 72-year-old male presented with loss of vision in left eye of 1 year duration. Patient had been diagnosed with wet neovascular age related macular degeneration in left eye and had received multiple injections of anti- vascular endothelial growth factor agents in past. Clinical and imaging studies showed persistent subretinal fluid. The patient was shifted to intravitreal Brolucizumab. There was complete resolution of subretinal fluid with improvement of vision 1 month following injection. Improvement of vison was maintained 3 months following injection with macula remaining dry.